1
|
Mercier J and Voutsadakis IA: A systematic
review and meta-analysis of retrospective series of regorafenib for
treatment of metastatic colorectal cancer. Anticancer Res.
37:5925–5934. 2017.PubMed/NCBI View Article : Google Scholar
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
3
|
Zhang Y, Lin C, Liao G, Liu S, Ding J,
Tang F, Wang Z, Liang X, Li B, Wei Y, et al: MicroRNA-506
suppresses tumor proliferation and metastasis in colon cancer by
directly targeting the oncogene EZH2. Oncotarget. 6:32586–32601.
2015.PubMed/NCBI View Article : Google Scholar
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Malapelle U, Mayo de-Las-Casas C, Rocco D,
Garzon M, Pisapia P, Jordana-Ariza N, Russo M, Sgariglia R, De Luca
C, Pepe F, et al: Development of a gene panel for next-generation
sequencing of clinically relevant mutations in cell-free DNA from
cancer patients. Br J Cancer. 116:802–810. 2017.PubMed/NCBI View Article : Google Scholar
|
6
|
Shahjaman M, Kumar N, Ahmed MS, Begum A,
Islam SMS and Mollah MNH: Robust feature selection approach for
patient classification using gene expression data. Bioinformation.
13:327–332. 2017.PubMed/NCBI View Article : Google Scholar
|
7
|
Strnad P, Paschke S, Jang KH and Ku NO:
Keratins: Markers and modulators of liver disease. Curr Opin
Gastroenterol. 28:209–216. 2012.PubMed/NCBI View Article : Google Scholar
|
8
|
Rogers MA, Edler L, Winter H, Langbein L,
Beckmann I and Schweizer J: Characterization of new members of the
human type II keratin gene family and a general evaluation of the
keratin gene domain on chromosome 12q13.13. J Invest Dermatol.
124:536–544. 2005.PubMed/NCBI View Article : Google Scholar
|
9
|
Uenishi T, Kubo S, Yamamoto T, Shuto T,
Ogawa M, Tanaka H, Tanaka S, Kaneda K and Hirohashi K: Cytokeratin
19 expression in hepatocellular carcinoma predicts early
postoperative recurrence. Cancer Sci. 94:851–857. 2003.PubMed/NCBI View Article : Google Scholar
|
10
|
Kurokawa I, Urakawa Y, Senba Y, Kawabata
E, Nishimura K, Omoto Y, Tokime K, Mizutani H and Tsubura A:
Keratin profiles may differ between intraepidermal and intradermal
invasive eccrine porocarcinoma. Oncol Rep. 16:473–477.
2006.PubMed/NCBI
|
11
|
Toivola DM, Boor P, Alam C and Strnad P:
Keratins in health and disease. Curr Opin Cell Biol. 32:73–81.
2015.PubMed/NCBI View Article : Google Scholar
|
12
|
Omary MB, Ku NO, Strnad P and Hanada S:
Toward unraveling the complexity of simple epithelial keratins in
human disease. J Clin Invest. 119:1794–1805. 2009.PubMed/NCBI View
Article : Google Scholar
|
13
|
Govaere O, Komuta M, Berkers J, Spee B,
Janssen C, de Luca F, Katoonizadeh A, Wouters J, van Kempen LC,
Durnez A, et al: Keratin 19: A key role player in the invasion of
human hepatocellular carcinomas. Gut. 63:674–685. 2014.PubMed/NCBI View Article : Google Scholar
|
14
|
Schweizer J, Bowden PE, Coulombe PA,
Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA,
Rogers MA and Wright MW: New consensus nomenclature for mammalian
keratins. J Cell Biol. 174:169–174. 2006.PubMed/NCBI View Article : Google Scholar
|
15
|
Jacob JT, Coulombe PA, Kwan R and Omary
MB: Types I and II keratin intermediate filaments. Cold Spring Harb
Perspect Biol. 10(a018275)2018.PubMed/NCBI View Article : Google Scholar
|
16
|
Baribault H, Penner J, Iozzo RV and
Wilson-Heiner M: Colorectal hyperplasia and inflammation in keratin
8-deficient FVB/N mice. Genes Dev. 8:2964–2973. 1994.PubMed/NCBI View Article : Google Scholar
|
17
|
Misiorek JO, Lähdeniemi IAK, Nyström JH,
Paramonov VM, Gullmets JA, Saarento H, Rivero-Müller A, Husøy T,
Taimen P and Toivola DM: Keratin 8-deletion induced colitis
predisposes to murine colorectal cancer enforced by the
inflammasome and IL-22 pathway. Carcinogenesis. 37:777–786.
2016.PubMed/NCBI View Article : Google Scholar
|
18
|
Lähdeniemi IAK, Misiorek JO, Antila CJM,
Landor SK, Stenvall CA, Fortelius LE, Bergström LK, Sahlgren C and
Toivola DM: Keratins regulate colonic epithelial cell
differentiation through the Notch1 signalling pathway. Cell Death
Differ. 24:984–996. 2017.PubMed/NCBI View Article : Google Scholar
|
19
|
Li C, Liu X, Liu Y, Liu X, Wang R, Liao J,
Wu S, Fan J, Peng Z, Li B and Wang Z: Keratin 80 promotes migration
and invasion of colorectal carcinoma by interacting with PRKDC via
activating the AKT pathway. Cell Death Dis. 9(1009)2018.PubMed/NCBI View Article : Google Scholar
|
20
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43(e47)2015.PubMed/NCBI View Article : Google Scholar
|
21
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004.PubMed/NCBI View Article : Google Scholar
|
22
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012.PubMed/NCBI View Article : Google Scholar
|
23
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6(pl1)2013.PubMed/NCBI View Article : Google Scholar
|
24
|
Jassal B, Matthews L, Viteri G, Gong C,
Lorente P, Fabregat A, Sidiropoulos K, Cook J, Gillespie M, Haw R,
et al: The reactome pathway knowledgebase. Nucleic Acids Res. 48
(D1):D498–D503. 2020.PubMed/NCBI View Article : Google Scholar
|
25
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.
2010.PubMed/NCBI View Article : Google Scholar
|
26
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
27
|
Wang C, Li A, Yang S, Qiao R, Zhu X and
Zhang J: CXCL5 promotes mitomycin C resistance in non-muscle
invasive bladder cancer by activating EMT and NF-κB pathway.
Biochem Biophys Res Commun. 498:862–868. 2018.PubMed/NCBI View Article : Google Scholar
|
28
|
Figueiredo J, da Cruz E Silva OA and
Fardilha M: Protein phosphatase 1 and its complexes in
carcinogenesis. Curr Cancer Drug Targets. 14:2–29. 2014.PubMed/NCBI View Article : Google Scholar
|
29
|
Zhang Q, Shan G, Cao P, He J, Lin Z, Huang
Y and Ao N: Mechanical and biological properties of oxidized horn
keratin. Mater Sci Eng C Mater Biol Appl. 47:123–134.
2015.PubMed/NCBI View Article : Google Scholar
|
30
|
Tang J, Zhuo H, Zhang X, Jiang R, Ji J,
Deng L, Qian X, Zhang F and Sun B: A novel biomarker Linc00974
interacting with KRT19 promotes proliferation and metastasis in
hepatocellular carcinoma. Cell Death Dis. 5(e1549)2014.PubMed/NCBI View Article : Google Scholar
|
31
|
Czapiewski P, Bobowicz M, Pęksa R,
Skrzypski M, Gorczyński A, Szczepańska-Michalska K, Korwat A,
Jankowski M, Zegarski W, Szulgo-Paczkowska A, et al: Keratin 7
expression in lymph node metastases but not in the primary tumour
correlates with distant metastases and poor prognosis in colon
carcinoma. Pol J Pathol. 67:228–234. 2016.PubMed/NCBI View Article : Google Scholar
|
32
|
Chen M, Wan L, Zhang J, Zhang J, Mendez L,
Clohessy JG, Berry K, Victor J, Yin Q, Zhu Y, et al: Deregulated
PP1α phosphatase activity towards MAPK activation is antagonized by
a tumor suppressive failsafe mechanism. Nat Commun.
9(159)2018.PubMed/NCBI View Article : Google Scholar
|
33
|
Sun H, Ou B, Zhao S, Liu X, Song L, Liu X,
Wang R and Peng Z: USP11 promotes growth and metastasis of
colorectal cancer via PPP1CA-mediated activation of ERK/MAPK
signaling pathway. EBioMedicine. 48:236–247. 2019.PubMed/NCBI View Article : Google Scholar
|
34
|
Hnit SS, Xie C, Yao M, Holst J, Bensoussan
A, De Souza P, Li Z and Dong Q: p27(Kip1) signaling:
Transcriptional and post-translational regulation. Int J Biochem
Cell Biol. 68:9–14. 2015.PubMed/NCBI View Article : Google Scholar
|
35
|
Sharma SS and Pledger WJ: The
non-canonical functions of p27(Kip1) in normal and tumor biology.
Cell Cycle. 15:1189–1201. 2016.PubMed/NCBI View Article : Google Scholar
|
36
|
Currier AW, Kolb EA, Gorlick RG, Roth ME,
Gopalakrishnan V and Sampson VB: p27/Kip1 functions as a tumor
suppressor and oncoprotein in osteosarcoma. Sci Rep.
9(6161)2019.PubMed/NCBI View Article : Google Scholar
|
37
|
Phillips AH, Ou L, Gay A, Besson A and
Kriwacki RW: Mapping interactions between p27 and RhoA that
stimulate cell migration. J Mol Biol. 430:751–758. 2018.PubMed/NCBI View Article : Google Scholar
|
38
|
Shamloo B and Usluer S: p21 in cancer
research. Cancers (Basel). 11(1178)2019.PubMed/NCBI View Article : Google Scholar
|
39
|
Karimian A, Ahmadi Y and Yousefi B:
Multiple functions of p21 in cell cycle, apoptosis and
transcriptional regulation after DNA damage. DNA Repair (Amst).
42:63–71. 2016.PubMed/NCBI View Article : Google Scholar
|
40
|
Huang Y, Wang W, Chen Y, Huang Y, Zhang J,
He S, Tan Y, Qiang F, Li A, Røe OD, et al: The opposite prognostic
significance of nuclear and cytoplasmic p21 expression in
resectable gastric cancer patients. J Gastroenterol. 49:1441–1452.
2014.PubMed/NCBI View Article : Google Scholar
|
41
|
Koster R, di Pietro A, Timmer-Bosscha H,
Gibcus JH, van den Berg A, Suurmeijer AJ, Bischoff R, Gietema JA
and de Jong S: Cytoplasmic p21 expression levels determine
cisplatin resistance in human testicular cancer. J Clin Invest.
120:3594–3605. 2010.PubMed/NCBI View Article : Google Scholar
|
42
|
Georgakilas AG, Martin OA and Bonner WM:
p21: A two-faced genome guardian. Trends Mol Med. 23:310–319.
2017.PubMed/NCBI View Article : Google Scholar
|
43
|
Denicourt C, Saenz CC, Datnow B, Cui XS
and Dowdy SF: Relocalized p27Kip1 tumor suppressor functions as a
cytoplasmic metastatic oncogene in melanoma. Cancer Res.
67:9238–9243. 2007.PubMed/NCBI View Article : Google Scholar
|